Is Myfortic still in shortage in 2026? Get the latest update on Myfortic availability, pricing, and what kidney transplant patients can do right now.
If you rely on Myfortic (Mycophenolic Acid) to protect your transplanted kidney, you've probably felt the squeeze. Over the past couple of years, patients have reported difficulty finding both brand-name Myfortic and its generic equivalents at their local pharmacies. In 2026, the situation has improved in some areas — but problems persist for many patients.
This article gives you the straight story on where things stand with the Myfortic supply in 2026, what's driving the issues, and exactly what you can do to make sure you don't run out.
The short answer: it depends on which version and where you live.
Brand-name Myfortic from Novartis has generally remained available throughout the supply disruptions. Novartis has continued to manufacture and distribute the 180 mg and 360 mg delayed-release tablets.
Generic Mycophenolic Acid delayed-release tablets are a different story. According to the American Society of Health-System Pharmacists (ASHP), Mycophenolate Sodium delayed-release tablets have been listed on the drug shortage database. Some generic manufacturers have experienced intermittent production disruptions that affect availability at retail pharmacies.
Mylan (now Viatris) has maintained availability of their generic version, but not all pharmacies carry it. If your pharmacy typically stocks a different generic manufacturer's product, you may hit a wall.
Several factors are converging:
The generic pharmaceutical supply chain is surprisingly fragile. When one manufacturer has a production issue — quality control problems, raw material shortages, equipment maintenance — it creates a ripple effect. With only a handful of companies making generic Mycophenolic Acid delayed-release tablets, losing even one producer for a few months tightens supply significantly.
Myfortic is classified as a specialty medication. Unlike high-volume drugs, specialty medications move through more targeted distribution channels. Many large chain pharmacies don't keep Myfortic on their regular shelves — they order it on demand. When the supply chain is tight, these on-demand orders may go unfilled.
The number of kidney transplants performed in the United States has been rising, with over 27,000 performed annually in recent years. More transplants mean more patients needing long-term immunosuppression, increasing overall demand for drugs like Myfortic.
For a deeper dive into why this drug is hard to find, see: Why Is Myfortic So Hard to Find? [Explained for 2026].
Cost continues to be a factor, especially for patients whose insurance requires them to switch between brand and generic based on what's available:
The price gap between brand and generic is significant, which is why generic shortages hit patients so hard. If the $43 generic isn't available and you're forced to the $850 brand, that's a real problem.
For help managing costs, read: How to Save Money on Myfortic in 2026: Coupons, Discounts, and Patient Assistance.
While no brand-new Mycophenolic Acid products have launched recently, patients have more tools than ever to navigate supply issues:
Medfinder lets you search real-time pharmacy availability for Myfortic and generic Mycophenolic Acid near you. Instead of calling pharmacy after pharmacy, you can see who has stock in seconds.
Novartis continues to offer their savings program through SaveOnMyPrescription.com. Patients with any payer type — including Medicare, Medicaid, commercial insurance, and uninsured — can check eligibility. This is particularly helpful if you need to switch to brand-name Myfortic while the generic is unavailable.
Transplant centers have increasingly partnered with specialty pharmacy networks that prioritize immunosuppressant inventory. If you haven't already, ask your transplant coordinator about connecting with a specialty pharmacy.
If you're running low, here's your action plan:
For detailed tips, see: How to Find Myfortic in Stock Near You (Tools + Tips).
The Myfortic supply situation in 2026 isn't a full-blown crisis, but it's not normal either. Brand-name Myfortic remains largely available, while generic supply continues to be inconsistent. The result is that some patients face unnecessary stress and gaps in their medication.
The best thing you can do is stay proactive. Refill early, have a backup pharmacy identified, know your alternatives, and use tools like Medfinder to stay ahead of the supply curve. Your kidney transplant is worth protecting — and so is your peace of mind.
Related reading:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
